GlassScriptPhysician profile
Aimee Plattsmier
NPI 1659959674
$2,503.67
in general payments reported to CMS, 2019-2025
28 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $436 · 2022: $606 · 2023: $445 · 2024: $717 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,462.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $326.65 | 2022 | |
| Paratek Pharmaceuticals, INC. | $298.63 | 2021-2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $213.41 | 2022-2024 | Verquvo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $187.93 | 2021-2024 | Xifaxan, Trulance |
| Abiomed | $155.71 | 2024-2025 | Impella |
| Urovant Sciences INC | $145.50 | 2021 | |
| Inari Medical, INC. | $145.06 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $128.38 | 2023-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $104.54 | 2024 | |
| Novartis Pharmaceuticals Corporation | $99.23 | 2021-2023 | |
| Exact Sciences Corporation | $92.87 | 2023-2025 | Cologuard Collection Kit |
| Horizon Therapeutics Plc | $77.75 | 2022 | |
| Sun Pharmaceutical Industries INC. | $57.72 | 2021 | |
| Immedica Pharma US, INC. | $54.40 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $50.40 | 2024-2025 | Caplyta |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $45.92 | 2024 | Skyclarys |
| Inspire Medical Systems, INC. | $44.16 | 2024 | Inspire |
| Viatris Specialty LLC | $39.99 | 2025 | Yupelri |
| Novo Nordisk INC | $37.40 | 2025 | Ozempic |
| Kowa Pharmaceuticals America, INC. | $24.86 | 2022-2023 | Seglentis |
| Lilly USA, LLC | $24.61 | 2024 | Mounjaro, Zepbound |
| Alexion Pharmaceuticals, INC. | $24.11 | 2022 | |
| Acadia Pharmaceuticals INC | $23.37 | 2021 | |
| Sumitomo Pharma America, INC. | $23.34 | 2023 | Gemtesa |
| Renalytix Ai, INC. | $20.37 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Shield Therapeutics INC | $19.49 | 2024 | |
| Avanir Pharmaceuticals, INC. | $19.42 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.45 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Plattsmier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.